Meet the Team
Chief Executive Officer & Co-Founder
Asaf Zviran
Experienced entrepreneur, scientist, and executive with over 20 years of product development, business development, and team management in defense and biotech. Previously, the Co-Founder, CEO & CSO of C2i Genomics, taking the company from a research concept to a global commercial leader.
​
Chief Science Officer & Co-Founder
Orly Alter
Inventor of the “Eigengene.” USTAR associate professor at the Scientific Computing and Imaging Institute and the Huntsman Cancer Institute at the University of Utah, and a member of the scientific advisory board of the NCI-DOE Cancer Moonshot collaboration on predictive oncology.
​
Chief Technology Officer
Daniel Shabtai
Technology leader with 11 years of experience from Facebook/Meta in leading engineering roles. Built and managed high-performing engineering organizations of over 300 people across multiple locations. Utilized AI/ML, scalable systems design, and data privacy concepts for products at large scale with billions of users.
Non-Executive Board Director
David Sidransky
Dr. Sidransky is a renowned oncologist, research scientist, and serial entrepreneur, profiled by TIME magazine in 2001 as one of America's best in science and medicine. A leading expert in oncology and precision medicine, Dr. Sidransky is widely respected in the biopharmaceutical industry.
​